Universal Vision Biotechnology Statistics

Total Valuation

Universal Vision Biotechnology has a market cap or net worth of TWD 18.39 billion. The enterprise value is 17.83 billion.

Market Cap	18.39B
Enterprise Value	17.83B

Important Dates

The last earnings date was Monday, November 11, 2024.

Earnings Date	Nov 11, 2024
Ex-Dividend Date	n/a

Share Statistics

Universal Vision Biotechnology has 84.72 million shares outstanding. The number of shares has increased by 0.10% in one year.

Current Share Class	n/a
Shares Outstanding	84.72M
Shares Change (YoY)	+0.10%
Shares Change (QoQ)	+0.10%
Owned by Insiders (%)	26.84%
Owned by Institutions (%)	10.49%
Float	46.85M

Valuation Ratios

The trailing PE ratio is 17.09 and the forward PE ratio is 16.53.

PE Ratio	17.09
Forward PE	16.53
PS Ratio	4.39
PB Ratio	5.42
P/TBV Ratio	5.46
P/FCF Ratio	15.03
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.64, with an EV/FCF ratio of 14.57.

EV / Earnings	16.53
EV / Sales	4.26
EV / EBITDA	9.64
EV / EBIT	13.22
EV / FCF	14.57

Financial Position

The company has a current ratio of 2.05, with a Debt / Equity ratio of 0.39.

Current Ratio	2.05
Quick Ratio	1.81
Debt / Equity	0.39
Debt / EBITDA	0.75
Debt / FCF	1.13
Interest Coverage	75.79

Financial Efficiency

Return on equity (ROE) is 31.99% and return on invested capital (ROIC) is 18.96%.

Return on Equity (ROE)	31.99%
Return on Assets (ROA)	15.80%
Return on Capital (ROIC)	18.96%
Revenue Per Employee	10.43M
Profits Per Employee	2.69M
Employee Count	401
Asset Turnover	0.78
Inventory Turnover	5.85

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -25.26% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-25.26%
50-Day Moving Average	227.42
200-Day Moving Average	247.00
Relative Strength Index (RSI)	49.65
Average Volume (20 Days)	166,957

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Universal Vision Biotechnology had revenue of TWD 4.18 billion and earned 1.08 billion in profits. Earnings per share was 12.70.

Revenue	4.18B
Gross Profit	2.50B
Operating Income	1.35B
Pretax Income	1.35B
Net Income	1.08B
EBITDA	1.81B
EBIT	1.35B
Earnings Per Share (EPS)	12.70

Full Income Statement

Balance Sheet

The company has 2.07 billion in cash and 1.38 billion in debt, giving a net cash position of 692.83 million or 8.18 per share.

Cash & Cash Equivalents	2.07B
Total Debt	1.38B
Net Cash	692.83M
Net Cash Per Share	8.18
Equity (Book Value)	3.53B
Book Value Per Share	40.04
Working Capital	1.51B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.63 billion and capital expenditures -410.37 million, giving a free cash flow of 1.22 billion.

Operating Cash Flow	1.63B
Capital Expenditures	-410.37M
Free Cash Flow	1.22B
FCF Per Share	14.44

Full Cash Flow Statement

Margins

Gross margin is 59.77%, with operating and profit margins of 32.23% and 25.79%.

Gross Margin	59.77%
Operating Margin	32.23%
Pretax Margin	32.18%
Profit Margin	25.79%
EBITDA Margin	43.23%
EBIT Margin	32.23%
FCF Margin	29.25%

Dividends & Yields

This stock pays an annual dividend of 7.00, which amounts to a dividend yield of 3.22%.

Dividend Per Share	7.00
Dividend Yield	3.22%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	10
Payout Ratio	54.98%
Buyback Yield	-0.10%
Shareholder Yield	3.12%
Earnings Yield	5.85%
FCF Yield	6.65%

Dividend Details

Stock Splits

The last stock split was on August 25, 2023. It was a forward split with a ratio of 1.06.

Last Split Date	Aug 25, 2023
Split Type	Forward
Split Ratio	1.06

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a